Found 162 presentations matching your search
Sodium glucose cotransporter 2 (sglt2) inhibitors and the effect on the heart and chronic kidney dis...
sglt2i inhibitor and dka
SGLT2 INHIBITORS are very new therapeutic agents for the management of Type2 DM.They are very unique...
Insulin secretagogues 2 : 1. Sulfonylurea drugs. 2. Meglitinides. 1 3. Incretin mimetics. Insulin se...
Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors such as Dapagliflozin (Farxiga), Canagliflozi...
Farmakovigilans untuk antidiabetikum berfokus pada pemantauan efek samping, interaksi obat, serta ke...
Antidiabetic drugs are those drugs that reduce blood sugar levels by releasing insulin or overcoming...
Dapagliflozin is a newer antidiabetic drug that belongs to the gliflozin class family. This class is...
SGLT2 inhibitor for treatment of HF
Heart failure means that the heart is unable to pump blood around the body properly. It usually happ...
Management of CAD in Diabetes the cardiovascular equivalent is challenging.The slides take you from ...
Dapagliflozin
Diabetes mellitus (DM) is a metabolic disorder in which person has high levels of glucose in blood. ...
1ANÁLOGOS DE INCRETINAS
2 Chloro 5 Iodobenzoic Acid plays a significant role as a scaffold in advancing type 2 diabetes trea...
The use of 2 Chloro 5 Iodobenzoic Acid as a scaffold is a promising development in type 2 diabetes t...
T2DM Management
Comparion of Empagliflozin and Dapagliflozin in diabetic treatment for Heart disease patient
SGLT-2 Diabetes
Anti diabetic drugs
Cardiovascular disease.
Cardiorenal metabolic management is important to reduce mortality risk
Dapagliflozin in nondiabetic CKD
Revisão sistemática com meta-análise sobre os inibidores do co-transportador sódio-glicose 2 nos...
